Cargando…
Glucosylceramide Associated with Gaucher Disease Forms Amyloid-like Twisted Ribbon Fibrils That Induce α-Synuclein Aggregation
[Image: see text] A major risk factor for Gaucher’s disease is loss of function mutations in the GBA1 gene that encodes lysosomal β-glucocerebrosidase, resulting in accumulation of glucosylceramide (GlcCer), a key lysosomal sphingolipid. GBA1 mutations also enhance the risk for Parkinson’s disease,...
Autores principales: | Paul, Ashim, Jacoby, Guy, Laor Bar-Yosef, Dana, Beck, Roy, Gazit, Ehud, Segal, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397424/ https://www.ncbi.nlm.nih.gov/pubmed/34213307 http://dx.doi.org/10.1021/acsnano.1c02957 |
Ejemplares similares
-
Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease
por: Paul, Ashim, et al.
Publicado: (2019) -
Branched-Chain Amino Acid Assembly into Amyloid-like Fibrils Provides a New Paradigm for Maple Syrup Urine Disease Pathology
por: Kreiser, Topaz, et al.
Publicado: (2023) -
Inhibitory Effect of Naphthoquinone-Tryptophan Hybrid towards Aggregation of PAP f39 Semen Amyloid
por: Viswanathan, Guru KrishnaKumar, et al.
Publicado: (2018) -
Ubiquitous Transgene Expression of the Glucosylceramide-Synthesizing Enzyme Accelerates Glucosylceramide Accumulation and Storage Cells in a Gaucher Disease Mouse Model
por: Barnes, Sonya, et al.
Publicado: (2014) -
Yeast Models for the Study of Amyloid-Associated Disorders and Development of Future Therapy
por: Rencus-Lazar, Sigal, et al.
Publicado: (2019)